Neuralink plans to scale production of its brain-computer interface and begin “high-volume production” of implants in 2026, reports Cape {town} Etc.
According to Reuters the announcement places the technology closer to wider clinical use for people with severe paralysis.
Neuralink’s implants have already allowed at least one recipient to control digital tools using thought, demonstrating the device’s assistive potential.
Cape {town} Etc Discount Alert! Unlock Cape Town’s best experiences for half the price! From unforgettable adventures to hidden gems and mouthwatering restaurants, these limited-time deals won’t last long. Snag your discount before they’re gone!
Neuralink began human trials in 2024 and has since expanded research activity, including a feasibility study pairing the implant with an investigational robotic arm. The company says further trials aim to test safety and practical benefits for people with spinal injuries.
Investors have supported the push towards mass production, which Neuralink and reporting note will require regulatory oversight, manufacturing scale-up and new surgical robotics.
‘We intend to move to an entirely automated surgical procedure in 2026,’ Musk wrote, underscoring the company’s focus on repeatable, hospital-ready processes.
Neuralink will start high-volume production of brain-computer interface devices and move to a streamlined, almost entirely automated surgical procedure in 2026.
Device threads will go through the dura, without the need to remove it. This is a big deal. https://t.co/nfNmtFHKsp
— Elon Musk (@elonmusk) December 31, 2025
Clinicians and disability advocates say rigorous trials and transparent safety data must accompany any rollout to protect patients and build public trust.
If those steps succeed, the next year could mark a defining moment for assistive neurotechnology and the people it aims to help.
Be the first to know – Join our WhatsApp Channel for content worth tapping into! Click here to join!
Also read:
Picture: @SERobinsonJr / X
